Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience

S. V. Kane, S. Horst, W. J. Sandborn, B. Becker, B. Neis, M. Moscandrew, K. A. Hanson, W. J. Tremaine, D. H. Bruining, W. A. Faubion, D. S. Pardi, W. S. Harmsen, A. R. Zinsmeister, E. V. Loftus

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint Dive into the research topics of 'Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience'. Together they form a unique fingerprint.

Medicine & Life Sciences